Greco A, Fusetti L, Miranda C, Villa R, Zanotti S, Pagliardini S, Pierotti M A
Division of Experimental Oncology A, Istituto Nazionale Tumori, Milan, Italy.
Oncogene. 1998 Feb 12;16(6):809-16. doi: 10.1038/sj.onc.1201596.
The thyroid TRK-T3 oncogene results from the fusion of the tyrosine kinase (TK) domain of NTRK1 (one of the receptors for the Nerve Growth Factor) on chromosome 1 to sequences of a novel gene, TFG, on chromosome 3. The 68 kDa TRK-T3 fusion oncoprotein displays a constitutive tyrosine kinase activity resulting in its capability to transform mouse NIH3T3 cells. The TFG portion of TRK-T3 contains a coiled-coil domain most likely responsible for the constitutive, ligand-independent activation of the receptor tyrosine kinase activity. We have previously shown that TRK-T3 oncoprotein forms, in vivo, complexes of three or four molecules. By mean of different experimental approaches, we show here that TRK-T3 activity depends on oligomers formation. In addition, the analysis of different TRK-T3 mutants indicates that the TFG coiled-coil domain and its N-terminal region are both required for the activation and the fully transforming activity of the TRK-T3 oncoprotein, although, most likely, they play a role in different steps of the transforming process. The deletion of the coiled-coil domain abrogates the oligomers formation leading to a constitutive activation; the deletion of the N-terminal region, although not affecting phosphorylation and complexes formation, abrogates transformation, thus suggesting a role in cellular localization and/or interaction with substrata.
甲状腺TRK-T3癌基因是由1号染色体上神经生长因子的一种受体NTRK1的酪氨酸激酶(TK)结构域与3号染色体上一个新基因TFG的序列融合而成。68 kDa的TRK-T3融合癌蛋白具有组成型酪氨酸激酶活性,使其能够转化小鼠NIH3T3细胞。TRK-T3的TFG部分包含一个卷曲螺旋结构域,很可能负责受体酪氨酸激酶活性的组成型、非配体依赖性激活。我们之前已经表明,TRK-T3癌蛋白在体内形成三分子或四分子复合物。通过不同的实验方法,我们在此表明TRK-T3活性取决于寡聚体的形成。此外,对不同TRK-T3突变体的分析表明,TFG卷曲螺旋结构域及其N端区域对于TRK-T3癌蛋白的激活和完全转化活性都是必需的,尽管它们很可能在转化过程的不同步骤中发挥作用。卷曲螺旋结构域的缺失消除了寡聚体的形成,导致组成型激活;N端区域的缺失虽然不影响磷酸化和复合物的形成,但消除了转化,因此表明其在细胞定位和/或与底物的相互作用中发挥作用。